Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3306 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

MFSI signs agreements for Bioagent Detector System

Under the agreement between MFSI and Applied Biosystems, Applied Biosystems will provide manufacturing of TaqMan assays, which are chemistry reagents that can detect harmful pathogens. The new systems

Znomics expands R&D facilities

The approximately 1,600-square-foot space will support the company’s drug discovery operations and will include a laboratory, fish facility, and offices, increasing Znomics’s current facilities by one-third. The company

UBC expands Regulatory Affairs group

The Regulatory Affairs group will be headed by Mark Ammann, a 17-year veteran of the pharmaceutical industry, who most recently held the position of global head of Regulatory

Foster Wheeler acquires Biokinetics

This acquisition enables Foster Wheeler to re-establish its position in the North American pharmaceutical market and strengthens its position relative to key US pharmaceutical companies seeking to invest

Opto Circuits to acquire Criticare Systems

Under the terms of the agreement, a wholly-owned subsidiary of Opto Circuits will make an all cash tender offer for all outstanding shares of Criticare common stock and